Mesa Laboratories, Inc.
MLABNASDAQTechnology● Active
$108.46
+$4.57(+4.40%)
Market Cap$599233908
P/E Ratio—
52W High$111.29
52W Low$55.45
Mesa Laboratories, Inc. (MLAB) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MLAB · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 27, 2026EPS Actual
$2.76
Est. $2.09 · +32.1%
Revenue
$0.06B
Est. $0.07B · -2.3%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 27, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue✓ 3-Quarter EPS Beat Streak
MLAB reports quarterly as a NASDAQ-listed Hardware, Equipment & Parts company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | $2.63 | — | — | — | $0.06B | — |
| ▲ Q2 FY2026 | May 27, 2026 | $2.09 | $2.76 | +32.1% | $0.06B | $0.07B | -2.3% |
| ▲ Q1 FY2026 | Feb 3, 2026 | $1.40 | $3.07 | +119.3% | $0.07B | $0.06B | +3.0% |
| ▲ Q4 FY2025 | Nov 6, 2025 | $1.56 | $1.76 | +12.8% | $0.06B | $0.06B | -0.5% |
| ▼ Q3 FY2025 | Aug 5, 2025 | $2.46 | $2.32 | -5.7% | $0.06B | $0.06B | -1.4% |
| ▼ Q2 FY2025 | May 28, 2025 | $2.75 | $2.23 | -18.9% | $0.06B | $0.06B | +0.4% |
| ▲ Q1 FY2025 | Feb 4, 2025 | $1.41 | $2.67 | +89.4% | $0.06B | $0.06B | +2.1% |
| ▼ Q4 FY2024 | Nov 7, 2024 | $2.48 | $2.45 | -1.2% | $0.06B | $0.06B | -0.1% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
$2.63
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 27, 2026Beat
EPS Actual
$2.76
EPS Est.
$2.09
EPS Surpr.
+32.1%
Revenue
$0.06B
Q1 FY2026
Feb 3, 2026Beat
EPS Actual
$3.07
EPS Est.
$1.40
EPS Surpr.
+119.3%
Revenue
$0.07B
Q4 FY2025
Nov 6, 2025Beat
EPS Actual
$1.76
EPS Est.
$1.56
EPS Surpr.
+12.8%
Revenue
$0.06B
Q3 FY2025
Aug 5, 2025Miss
EPS Actual
$2.32
EPS Est.
$2.46
EPS Surpr.
-5.7%
Revenue
$0.06B
Q2 FY2025
May 28, 2025Miss
EPS Actual
$2.23
EPS Est.
$2.75
EPS Surpr.
-18.9%
Revenue
$0.06B
Q1 FY2025
Feb 4, 2025Beat
EPS Actual
$2.67
EPS Est.
$1.41
EPS Surpr.
+89.4%
Revenue
$0.06B
Q4 FY2024
Nov 7, 2024Miss
EPS Actual
$2.45
EPS Est.
$2.48
EPS Surpr.
-1.2%
Revenue
$0.06B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2029 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2028 | $2.97 | $3.06 | $3.15 | 1 |
| Q4 FY2027 | $3.00 | $3.09 | $3.18 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2029 | $0.1B | $0.1B | $0.1B | 2 |
| Q4 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q1 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 27, 2026 | +32.1% | $106.17 | $90.80 | -14.48% |
| ▲ Q1 FY2026 | Feb 3, 2026 | +119.3% | $80.50 | $87.53 | +8.73% |
| ▲ Q4 FY2025 | Nov 6, 2025 | +12.8% | $74.20 | $74.87 | +0.90% |
| ▼ Q3 FY2025 | Aug 5, 2025 | -5.7% | $76.50 | $57.44 | -24.92% |
| ▼ Q2 FY2025 | May 28, 2025 | -18.9% | $113.20 | $103.07 | -8.95% |
| ▲ Q1 FY2025 | Feb 4, 2025 | +89.4% | $133.93 | $137.27 | +2.49% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -1.2% | $134.16 | $117.89 | -12.13% |
| ▲ Q3 FY2024 | Aug 5, 2024 | +21.5% | $106.90 | $104.71 | -2.05% |
Q2 FY2026-14.48%
Report Date
May 27, 2026
EPS Beat/Miss
+32.1%
Price Before
$106.17
Price After
$90.80
Q1 FY2026+8.73%
Report Date
Feb 3, 2026
EPS Beat/Miss
+119.3%
Price Before
$80.50
Price After
$87.53
Q4 FY2025+0.90%
Report Date
Nov 6, 2025
EPS Beat/Miss
+12.8%
Price Before
$74.20
Price After
$74.87
Q3 FY2025-24.92%
Report Date
Aug 5, 2025
EPS Beat/Miss
-5.7%
Price Before
$76.50
Price After
$57.44
Q2 FY2025-8.95%
Report Date
May 28, 2025
EPS Beat/Miss
-18.9%
Price Before
$113.20
Price After
$103.07
Q1 FY2025+2.49%
Report Date
Feb 4, 2025
EPS Beat/Miss
+89.4%
Price Before
$133.93
Price After
$137.27
Q4 FY2024-12.13%
Report Date
Nov 7, 2024
EPS Beat/Miss
-1.2%
Price Before
$134.16
Price After
$117.89
Q3 FY2024-2.05%
Report Date
Aug 5, 2024
EPS Beat/Miss
+21.5%
Price Before
$106.90
Price After
$104.71
Avg Beat Reaction-0.88%
Avg Miss Reaction-15.33%
Beat Rate5 / 8 quarters
Largest Move-24.92% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MLAB ends December
Mesa Laboratories, Inc. (MLAB) most recently reported earnings on May 27, 2026 for Q2 FY2026, posting EPS of $2.76 — beating the analyst consensus of $2.09 by +32.1%. MLAB has beaten EPS estimates for 3 consecutive quarters. The next MLAB earnings date is expected around September 1, 2026.
Each quarter, investors track MLAB earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MLAB revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MLAB's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MLAB earnings · 5 questionsMesa Laboratories, Inc.'s next earnings report is expected around September 1, 2026. MLAB typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MLAB historically reports after market close (AMC).
MLAB earnings datewhen is MLAB earningsMLAB next earnings datewhen does MLAB report earningsMLAB earnings calendar
▸ Source: FMP · Mesa Laboratories, Inc. SEC filings · US GAAP · Mesa Laboratories, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026